PRIMARY OBJECTIVES:
I. To evaluate the patients’ preference of TXT-Chatbot approach versus MyChart/Patient Portal approach, considering their demographic information.
II. To evaluate each patient’s adherence to the approach of his/her own choice by examining their utilization of the ePRO.
SECONDARY OBJECTIVE:
I. To examine the usability and satisfaction of the two implementation approaches of each patient’s choice.
EXPLORATORY OBJECTIVE:
I. To explore and measure any differences in patients’ preference of TXT-Chatbot approach versus MyChart/Patient Portal approach, as well as the number of completed of ePRO responses, in the course of 6 months, reported between race (African American versus [vs.] Caucasian) and approaches (Chatbot vs. MyChart/Patient Portal).
OUTLINE: Patients are assigned to 1 of 2 groups.
GROUP I: Patients receive a text message notification and complete surveys through TXT-Chatbot once every two weeks (Q2W) for 6 months.
GROUP II: Patients receive an email notification and complete surveys through MyChart/Patient Portal Q2W for 6 months.
After completion of study intervention, patients are followed up for 30 days.
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
